Just looked at the other biotechs and they are down big. Guess the nugget is that it is not isolated to MNTA. Wonder if a fund is liquidating, short of cash, etc or simple domino effect. Also, why the concern of end of month holdings rather than the typical end of quarter? Am I missing something here?
Market Data 
Markets 
AI
